Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

colorectal cancer

  • The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of <sup>90</sup>Y SIRT in Colorectal Cancer Patients
    You have access
    The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of 90Y SIRT in Colorectal Cancer Patients
    Elliot M. Abbott, Nadia Falzone, Boon Q. Lee, Christiana Kartsonaki, Helen Winter, Tessa A. Greenhalgh, Daniel R. McGowan, Nigar Syed, Ana M. Denis-Bacelar, Philip Boardman, Ricky A. Sharma and Katherine A. Vallis
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1658-1664; DOI: https://doi.org/10.2967/jnumed.119.233650
  • You have access
    The Optimal Imaging Window for Dysplastic Colorectal Polyp Detection Using c-Met–Targeted Fluorescence Molecular Endoscopy
    Steven J. de Jongh, Josephina P.M. Vrouwe, Floris J. Voskuil, Iris Schmidt, Jessie Westerhof, Jan J. Koornstra, Marieke L. de Kam, Arend Karrenbeld, James C.H. Hardwick, Dominic J. Robinson, Jacobus Burggraaf, Ingrid M.C. Kamerling and Wouter B. Nagengast
    Journal of Nuclear Medicine October 1, 2020, 61 (10) 1435-1441; DOI: https://doi.org/10.2967/jnumed.119.238790
  • You have access
    68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
    Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Labidi Abderrahim, Annette Altmann, Walter Mier, Sebastian Adeberg, Hendrik Rathke, Manuel Röhrich, Hauke Winter, Peter K. Plinkert, Frederik Marme, Matthias Lang, Hans-Ulrich Kauczor, Dirk Jäger, Jürgen Debus, Uwe Haberkorn and Frederik L. Giesel
    Journal of Nuclear Medicine June 1, 2019, 60 (6) 801-805; DOI: https://doi.org/10.2967/jnumed.119.227967
  • You have access
    Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer
    Sarah M. Cheal, Edward K. Fung, Mitesh Patel, Hong Xu, Hong-fen Guo, Pat B. Zanzonico, Sebastien Monette, K. Dane Wittrup, Nai-Kong V. Cheung and Steven M. Larson
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1735-1742; DOI: https://doi.org/10.2967/jnumed.117.193250
  • You have access
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
    F. Edward Boas, Lisa Bodei and Constantinos T. Sofocleous
    Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
  • You have access
    Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model
    Marlène C.H. Hekman, Mark Rijpkema, Desirée L. Bos, Egbert Oosterwijk, David M. Goldenberg, Peter F.A. Mulders and Otto C. Boerman
    Journal of Nuclear Medicine May 1, 2017, 58 (5) 706-710; DOI: https://doi.org/10.2967/jnumed.116.185470
  • You have access
    99mTc-Duramycin SPECT Imaging of Early Tumor Response to Targeted Therapy: A Comparison with 18F-FDG PET
    Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants and Leonie Wyffels
    Journal of Nuclear Medicine April 1, 2017, 58 (4) 665-670; DOI: https://doi.org/10.2967/jnumed.116.182014
  • You have access
    Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer
    Vessela Vassileva, Vineeth Rajkumar, Mario Mazzantini, Mathew Robson, Adam Badar, Surinder Sharma, Erik Årstad, Daniel Hochhauser, Mark F. Lythgoe, Geoffrey M. Boxer and Rosmund Barbara Pedley
    Journal of Nuclear Medicine August 1, 2015, 56 (8) 1239-1245; DOI: https://doi.org/10.2967/jnumed.115.157362
  • You have access
    18F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management
    Charles Marcus, Wael Marashdeh, Se Jin Ahn, Mehdi Taghipour and Rathan M. Subramaniam
    Journal of Nuclear Medicine July 1, 2015, 56 (7) 989-994; DOI: https://doi.org/10.2967/jnumed.115.156240
  • You have access
    SPECT- and Fluorescence Image–Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen–Targeting Antibody
    Mark Rijpkema, Wim J. Oyen, Desiree Bos, Gerben M. Franssen, David M. Goldenberg and Otto C. Boerman
    Journal of Nuclear Medicine September 1, 2014, 55 (9) 1519-1524; DOI: https://doi.org/10.2967/jnumed.114.142141

Pages

  • Next
  • 1
  • 2
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire